-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
426,Cytiva(),FlexFactory™,、、、。,,,,、。
“”,。,、、、、,1000,325,15,2020,75%。
Among them, Guangzhou International Biological Island alone has become a gathering place for more than 500 biomedical companies, including AstraZeneca South China Headquarters, Merck Guangdong Innovation Center, BeiGene Global R&D Center, Golden Mile Medical Group Headquarters, Burning Rock Medical Headquarters Five pillar industries, including drug R&D, stem cell and regenerative medicine, precision medicine, medical equipment, and general health, have formed, including top pharmaceutical companies at home and abroad.
What is driving this small island butterfly with an area of less than 2 square kilometers into a new highland for the development of the biomedical industry in Guangdong Province? What factors have prompted many pharmaceutical companies to choose to settle on this small island? "Pharmaceutical Economic News" recently entered the Guangzhou International Biological Island and unveiled.
Around multiple pillar industries
Seize the high ground of global competition
Guangzhou International Biological Island, formerly known as "Guanzhou Island", is a Jiangxin Island located at the southeastern tip of Guangzhou City along the Pearl River Back Channel Development Zone, covering an area of approximately 1.
83 square kilometers.
In 2000, the project was formally approved by the state and named Guangzhou International Biological Island.
According to the person in charge of the Guangzhou International Biological Island Management Committee, the national, provincial and municipal leaders have always attached great importance to the development of biological islands.
At this stage, Biological Island is gradually moving from a first-class incubator to the world's top biomedicine and biosafety research and development center.
The person in charge added that the locally cultivated Burning Stone Medicine has been at the forefront of the country in terms of companion diagnosis, early cancer screening and second-generation sequencing, starting from its establishment in Biological Island, and through 6 years of struggle.
Benchmarking a strong biomedical market
The largest support in the country
Today, Guangzhou International Bio-Island is making every effort to build the Guangdong-Hong Kong-Macao Greater Bay Area Life Science Cooperation Zone, the National Biomedicine Policy Innovation Pilot Zone, and the world's top biomedicine and biosafety research and development center in accordance with the requirements of the country, province, city and district.
In terms of policy support, Guangzhou has always been at the forefront of the country.
According to Huang Weijian, deputy director of the Guangzhou Development Zone Investment Promotion Bureau, the "10 Biomedicine Articles" also provide corresponding policy support for biological islands.
The aforementioned person in charge said that all the world's top biomedical parks have a very outstanding feature, that is, they are basically next to universities, because this can make full use of the talent resources of universities and continuously provide intellectual support for talents to the park.
Seize the opportunity of the times
Achieve high-quality development of the enterprise
As the protagonist on the biological island, why do many biomedical companies choose to use it as a place for new development in the future? From a corporate perspective, how do they evaluate the biological island?
Xia Yu, chairman of Kangfang Biotech, revealed at the signing ceremony that a clinical operation and R&D center will be established in Biological Island.
This time, Yu Lihua, general manager of the Greater China region of Situofan, who officially opened in Biological Island, said frankly: "Our vision is actually to follow users and follow the development of industrial policies.
Liang Yaoming, chairman and chief executive officer of Guangzhou Jinyu Medical Laboratory Group Co.
Facing future plans, Liang Yaoming said: “As the innovation node of the Guangdong-Hong Kong-Macao Greater Bay Area Science and Technology Innovation Corridor planning, as a leading company in third-party medical testing, Golden Mile Medical actively guides Hong Kong, Macao and even international high-end medical technology resources to come in.
As one of the few Fortune 500 companies currently stationed on the island, AstraZeneca has attracted much attention.
With the new crown epidemic still raging around the world, speeding up the development of biomedicine has become a world consensus.
The aforementioned person in charge stated that the Bio-Island Management Committee will provide a first-class international legalized business environment and government services, and strengthen linkages with science city, knowledge city and other sectors, as well as university city, Pazhou and other sectors, to complement each other's advantages and create the best Good industrial ecology.
I believe that Bio-Island will fulfill its mission in the future and play the role of the heart and brain of biomedicine research and development, biosafety, especially high-end biomedicine research and development in Guangzhou and even the Guangdong-Hong Kong-Macao Greater Bay Area, so that enterprises can develop high-quality here and develop protection Good medicine for the people of the world and make its due contribution.
It is reported that NMPA Southern Institute of Pharmaceutical Economics will set up a big data center in Guangzhou International Biological Island, and "Pharmaceutical Economics News" will also set up an office on the island.